Solana Company (HSDT) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
12 Nov, 2026Executive summary
Q3 net income was $105.16M, largely reflecting a $102.7M non-cash unrealized gain on digital assets as SOL rose; 9M net loss was $24.89M.
Pacific Backbone entered operation, with third-party stake reaching 1.0M SOL; advisory activity included 40+ institutional sessions and workshops across Asia-Pacific.
Treasury held 2,441,560 SOL valued at $288.2M at Sept. 30, equivalent to 0.0274 SOL per diluted share on a Treasury Stock Method basis.
Financial highlights
Q3 revenue was $3.36M, including $3.34M in staking revenue, versus $0.70M and $0.3M, respectively, in Q3 2025; 9M revenue was $9.51M.
Q3 gross profit was $2.74M on $617K cost of revenue, with ~82% gross margin; 9M gross profit was $8.63M.
Q3 operating income was $103.85M and net income was $105.16M, versus losses of $35.45M and $352.77M in Q3 2025; diluted EPS was $1.17.
9M operating loss was $28.4M and net loss was $24.89M, versus a $366.44M net loss in 9M 2025.
Q3 G&A was $3.4M versus $5.5M YoY; 9M G&A was $19.7M, including $6.8M of PoNS-divestiture severance.
Outlook and guidance
Priorities include growing Pacific Backbone third-party stake, assessing Hong Kong as a validator location, pursuing ISO 27001 certification, expanding institutional adoption and increasing SOL per share.
G&A is expected to normalize between current and historic run rates as operations grow; no forward OpEx guidance was provided.
Third-party stake growth may slow in Q4 after rising from a few hundred thousand SOL to over 1M; further adoption-driven growth is expected by Q1 2027.
Available cash and working capital were expected to cover liquidity needs for at least 12 months, assuming SOL can be liquidated when needed; market stress or reduced liquidity could challenge that assumption.
Latest events from Solana Company
- Q2 2026 revenue surged on staking, but net loss widened amid SOL losses and restructuring.HSDT
Q2 2026 - All director nominees and the auditor appointment were approved without shareholder questions.HSDT
AGM 2026 - Director nominee withdrawn, board size reduced, and new CEO and CFO appointed.HSDT
Proxy filing - Q1 2026 revenue surged on staking, but SOL volatility drove a $99.8M net loss.HSDT
Q1 2026 - Shareholders will vote on director elections, auditor ratification, and board changes at the virtual annual meeting.HSDT
Proxy filing - Annual meeting to elect directors, ratify auditor, and reinforce governance and sustainability.HSDT
Proxy filing - Q4 2025 delivered strong staking rewards, $325.6M net income, and 14% SOL per share growth.HSDT
Q4 2025 - CMS pricing delays hinder access and commercialization, prompting strategic review and regulatory focus.HSDT
Status Update - First third-party reimbursement and Medicare rates expected to drive late-2024 revenue growth.HSDT
Q2 2024